PHARMA MEDICO ApS Financials, key figures and credit report
Gross profit 32 265.7 kDKK FY 2025 +49.5% vs 2024
EBIT 20 270.2 kDKK FY 2025 +93.6% vs 2024
Net debt -28 653.5 kDKK FY 2025 -8.1% vs 2024
Quick ratio 5.0 FY 2025 -1.8 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 21 547.85 | 30 054.42 | 26 192.94 | 21 583.99 | 32 265.73 |
| Employee benefit expenses | -9 008.60 | -7 802.10 | -7 993.34 | -7 920.02 | -8 961.41 |
| Other operating expenses | - 149.00 | - 325.00 | -71.75 | ||
| Total depreciation | - 449.51 | - 493.99 | - 982.25 | -2 867.89 | -2 962.40 |
| EBIT | 11 940.74 | 21 758.32 | 17 217.36 | 10 471.09 | 20 270.17 |
| Other financial income | 1 049.07 | 33.55 | 945.64 | 993.07 | 393.52 |
| Other financial expenses | - 329.94 | - 769.08 | - 130.06 | - 244.08 | - 734.52 |
| Pre-tax profit | 12 659.87 | 21 022.80 | 18 032.95 | 11 220.08 | 19 929.17 |
| Income taxes | -2 277.14 | -4 584.75 | -4 014.32 | -2 611.11 | -4 521.44 |
| Net earnings | 10 382.73 | 16 438.05 | 14 018.63 | 8 608.97 | 15 407.74 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Development expenditure | 4 267.66 | 9 932.59 | 11 515.78 | 9 340.52 | 6 895.76 |
| Intangible assets total | 4 267.66 | 9 932.59 | 11 515.78 | 9 340.52 | 6 895.76 |
| Buildings | 575.69 | 339.15 | 1 597.02 | 1 235.07 | |
| Machinery and equipment | 626.77 | 500.77 | 733.71 | 572.28 | 678.01 |
| Tangible assets total | 1 202.46 | 839.92 | 733.71 | 2 169.29 | 1 913.08 |
| Investments total | |||||
| Non-current other receivables | 1 252.45 | 1 252.45 | |||
| Long term receivables total | 1 252.45 | 1 252.45 | |||
| Finished products/goods | 3 125.88 | 3 396.22 | 3 017.28 | 3 427.33 | 4 154.80 |
| Inventories total | 3 125.88 | 3 396.22 | 3 017.28 | 3 427.33 | 4 154.80 |
| Current trade debtors | 18 253.29 | 28 457.37 | 19 130.24 | 26 026.04 | 25 899.02 |
| Current amounts owed by group member comp. | 6 921.34 | 8 175.33 | 7 297.03 | 8 046.47 | 5 194.86 |
| Prepayments and accrued income | 731.74 | 833.45 | 826.63 | 33.19 | 166.10 |
| Current other receivables | 1 968.51 | 2 286.18 | 2 770.46 | 2 215.15 | 2 382.88 |
| Short term receivables total | 27 874.88 | 39 752.33 | 30 024.36 | 36 320.85 | 33 642.86 |
| Cash and bank deposits | 11 745.35 | 9 845.49 | 26 666.44 | 26 787.12 | 31 100.47 |
| Cash and cash equivalents | 11 745.35 | 9 845.49 | 26 666.44 | 26 787.12 | 31 100.47 |
| Balance sheet total (assets) | 48 216.23 | 63 766.55 | 71 957.57 | 79 297.55 | 78 959.41 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 126.25 | 126.25 | 126.25 | 126.25 | 126.25 |
| Shares repurchased | 4 500.00 | 6 000.00 | 20 000.00 | ||
| Other reserves | 3 328.77 | 7 747.42 | 2 982.31 | 7 285.60 | -14 621.31 |
| Retained earnings | 21 235.06 | 27 199.15 | 36 402.30 | 52 117.64 | 42 633.52 |
| Profit of the financial year | 10 382.73 | 16 438.05 | 14 018.63 | 8 608.97 | 15 407.74 |
| Shareholders equity total | 39 572.81 | 51 510.86 | 59 529.49 | 68 138.46 | 63 546.19 |
| Provisions | 845.30 | 2 125.00 | 2 444.00 | 1 979.00 | 1 427.00 |
| Non-current liabilities total | |||||
| Current loans from credit institutions | 294.94 | 158.76 | 171.35 | 121.40 | |
| Advances received | 1 104.32 | ||||
| Current trade creditors | 5 631.50 | 6 060.36 | 4 939.93 | 5 735.15 | 9 624.73 |
| Current owed to participating | 4.80 | 34.57 | 25.83 | 23.75 | 43.83 |
| Current owed to group member | 80.65 | 2 281.72 | |||
| Short-term deferred tax liabilities | 708.84 | 2 465.15 | 2 922.05 | 2 186.11 | 163.44 |
| Other non-interest bearing current liabilities | 1 116.60 | 1 275.67 | 1 937.52 | 983.08 | 646.79 |
| Accruals and deferred income | 336.37 | ||||
| Current liabilities total | 7 798.11 | 10 130.69 | 9 984.08 | 9 180.09 | 13 986.22 |
| Balance sheet total (liabilities) | 48 216.23 | 63 766.55 | 71 957.57 | 79 297.55 | 78 959.41 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated